Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May;38(5):e447-e449.
doi: 10.1111/jdv.19707. Epub 2023 Dec 12.

Immunotherapy-induced eczema treated with dupilumab

Angelo Massimiliano D'Erme  1 , Cristian Fidanzi  2 , Nicolò Mori  2 , Gianna Musettini  3 , Samanta Cupini  4 , Cecilia Barbara  4 , Giacomo Allegrini  4 , Giovanni Bagnoni  1 , Agata Janowska  2
Affiliations
Case Reports

Immunotherapy-induced eczema treated with dupilumab

Angelo Massimiliano D'Erme et al. J Eur Acad Dermatol Venereol. 2024 May.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Park JJ, Park E, Damsky WE, Vesely MD. Pembrolizumab‐induced lichenoid dermatitis treated with dupilumab. JAAD Case Rep. 2023;37:13–15.
    1. D'Erme AM, Fidanzi C, Janowska A, Allegrini G, Barbara C, Cupini S, et al. Psoriasis caused by pembrolizumab treatment in advanced melanoma: a positive prognostic side effect? Dermatol Ther. 2021;34(5):e15050. https://doi.org/10.1111/dth.15050
    1. Kuo AM‐S, Gu S, Stoll J, Moy AP, Dusza SW, Gordon A, et al. Management of immune‐related cutaneous adverse events with dupilumab. J Immunother Cancer. 2023;11:e007324. https://doi.org/10.1136/jitc‐2023‐007324
    1. Pop SR, Strock D, Smith RJ. Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: a case report. Dermatol Ther. 2022;35(8):e15623.
    1. Drago F, Cogorno L, Agnoletti AF, Ciccarese G, Parodi A. A retrospective study of cutaneous drug reactions in an outpatient population. Int J Clin Pharmacol. 2015;37(5):739–743. https://doi.org/10.1007/s11096‐015‐0134‐z

Substances

LinkOut - more resources